Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer

Masaru Morita, Hiroyuki Kuwano, Kohshi Araki, Akinori Egashira, Hidetoshi Kawaguchi, Hiroshi Saeki, Kaoru Kitamura, Shinji Ohno, Keizo Sugimachi

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Purpose: Lymphocyte infiltration (LI) around cancerous lesions is an important immune response. The purpose of this study is to evaluate the prognostic significance of LI after preoperative treatment for esophageal cancer. Methods and Materials: Preoperative chemoradiotherapy (CR therapy), either bleomycin 30 mg or cisplatin 120 mg/m2 plus radiation 30 Gy, was performed on 51 cases with esophageal cancer, while hyperthermo-chemoradiotherapy (HCR therapy) was also indicated in 71 cases. Using resected specimens, both the histopathologic effectiveness and degree of LI to cancerous lesions were evaluated. Results: The incidences of the cases in which preoperative treatment was effective were 56% and 92.3% in LI (-) and LI (++) group (p < 0.05). The presence of LI resulted in favorable prognosis; the 5-year survival rates of LI (++) and LI (+) patients were 75.5% and 46.1%, both of which were significantly better than LI (-) (27.8%, p < 0.05 and p < 0.01, respectively). Especially among cases whose preoperative treatment was moderately effective, a multivariate analysis revealed LI to be a favorable prognostic factor independent of other clinicopathologic factors (p = 0.0171). Regarding the preoperative treatment, the incidence of LI (++) was higher in the HCR group (16.9%) than in the CR group (2.0%, p < 0.01). Conclusions: LI appears to be a prognostic predictor after preoperative CR therapy while, in addition, simultaneous hyperthermia may stimulate LI in cases with esophageal cancer.

Original languageEnglish
Pages (from-to)1259-1266
Number of pages8
JournalInternational Journal of Radiation Oncology Biology Physics
Volume49
Issue number5
DOIs
Publication statusPublished - Apr 1 2001

Fingerprint

hyperthermia
lymphocytes
Chemoradiotherapy
infiltration
Esophageal Neoplasms
Fever
cancer
Lymphocytes
lesions
incidence
Radiation Dosage
prognosis
Incidence
Bleomycin
Therapeutics
Cisplatin
Multivariate Analysis
Survival Rate

All Science Journal Classification (ASJC) codes

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer. / Morita, Masaru; Kuwano, Hiroyuki; Araki, Kohshi; Egashira, Akinori; Kawaguchi, Hidetoshi; Saeki, Hiroshi; Kitamura, Kaoru; Ohno, Shinji; Sugimachi, Keizo.

In: International Journal of Radiation Oncology Biology Physics, Vol. 49, No. 5, 01.04.2001, p. 1259-1266.

Research output: Contribution to journalArticle

Morita, Masaru ; Kuwano, Hiroyuki ; Araki, Kohshi ; Egashira, Akinori ; Kawaguchi, Hidetoshi ; Saeki, Hiroshi ; Kitamura, Kaoru ; Ohno, Shinji ; Sugimachi, Keizo. / Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer. In: International Journal of Radiation Oncology Biology Physics. 2001 ; Vol. 49, No. 5. pp. 1259-1266.
@article{aa8abdcf09494358a35b4a9f731dbe80,
title = "Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer",
abstract = "Purpose: Lymphocyte infiltration (LI) around cancerous lesions is an important immune response. The purpose of this study is to evaluate the prognostic significance of LI after preoperative treatment for esophageal cancer. Methods and Materials: Preoperative chemoradiotherapy (CR therapy), either bleomycin 30 mg or cisplatin 120 mg/m2 plus radiation 30 Gy, was performed on 51 cases with esophageal cancer, while hyperthermo-chemoradiotherapy (HCR therapy) was also indicated in 71 cases. Using resected specimens, both the histopathologic effectiveness and degree of LI to cancerous lesions were evaluated. Results: The incidences of the cases in which preoperative treatment was effective were 56{\%} and 92.3{\%} in LI (-) and LI (++) group (p < 0.05). The presence of LI resulted in favorable prognosis; the 5-year survival rates of LI (++) and LI (+) patients were 75.5{\%} and 46.1{\%}, both of which were significantly better than LI (-) (27.8{\%}, p < 0.05 and p < 0.01, respectively). Especially among cases whose preoperative treatment was moderately effective, a multivariate analysis revealed LI to be a favorable prognostic factor independent of other clinicopathologic factors (p = 0.0171). Regarding the preoperative treatment, the incidence of LI (++) was higher in the HCR group (16.9{\%}) than in the CR group (2.0{\%}, p < 0.01). Conclusions: LI appears to be a prognostic predictor after preoperative CR therapy while, in addition, simultaneous hyperthermia may stimulate LI in cases with esophageal cancer.",
author = "Masaru Morita and Hiroyuki Kuwano and Kohshi Araki and Akinori Egashira and Hidetoshi Kawaguchi and Hiroshi Saeki and Kaoru Kitamura and Shinji Ohno and Keizo Sugimachi",
year = "2001",
month = "4",
day = "1",
doi = "10.1016/S0360-3016(00)01465-6",
language = "English",
volume = "49",
pages = "1259--1266",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Prognostic significance of lymphocyte infiltration following preoperative chemoradiotherapy and hyperthermia for esophageal cancer

AU - Morita, Masaru

AU - Kuwano, Hiroyuki

AU - Araki, Kohshi

AU - Egashira, Akinori

AU - Kawaguchi, Hidetoshi

AU - Saeki, Hiroshi

AU - Kitamura, Kaoru

AU - Ohno, Shinji

AU - Sugimachi, Keizo

PY - 2001/4/1

Y1 - 2001/4/1

N2 - Purpose: Lymphocyte infiltration (LI) around cancerous lesions is an important immune response. The purpose of this study is to evaluate the prognostic significance of LI after preoperative treatment for esophageal cancer. Methods and Materials: Preoperative chemoradiotherapy (CR therapy), either bleomycin 30 mg or cisplatin 120 mg/m2 plus radiation 30 Gy, was performed on 51 cases with esophageal cancer, while hyperthermo-chemoradiotherapy (HCR therapy) was also indicated in 71 cases. Using resected specimens, both the histopathologic effectiveness and degree of LI to cancerous lesions were evaluated. Results: The incidences of the cases in which preoperative treatment was effective were 56% and 92.3% in LI (-) and LI (++) group (p < 0.05). The presence of LI resulted in favorable prognosis; the 5-year survival rates of LI (++) and LI (+) patients were 75.5% and 46.1%, both of which were significantly better than LI (-) (27.8%, p < 0.05 and p < 0.01, respectively). Especially among cases whose preoperative treatment was moderately effective, a multivariate analysis revealed LI to be a favorable prognostic factor independent of other clinicopathologic factors (p = 0.0171). Regarding the preoperative treatment, the incidence of LI (++) was higher in the HCR group (16.9%) than in the CR group (2.0%, p < 0.01). Conclusions: LI appears to be a prognostic predictor after preoperative CR therapy while, in addition, simultaneous hyperthermia may stimulate LI in cases with esophageal cancer.

AB - Purpose: Lymphocyte infiltration (LI) around cancerous lesions is an important immune response. The purpose of this study is to evaluate the prognostic significance of LI after preoperative treatment for esophageal cancer. Methods and Materials: Preoperative chemoradiotherapy (CR therapy), either bleomycin 30 mg or cisplatin 120 mg/m2 plus radiation 30 Gy, was performed on 51 cases with esophageal cancer, while hyperthermo-chemoradiotherapy (HCR therapy) was also indicated in 71 cases. Using resected specimens, both the histopathologic effectiveness and degree of LI to cancerous lesions were evaluated. Results: The incidences of the cases in which preoperative treatment was effective were 56% and 92.3% in LI (-) and LI (++) group (p < 0.05). The presence of LI resulted in favorable prognosis; the 5-year survival rates of LI (++) and LI (+) patients were 75.5% and 46.1%, both of which were significantly better than LI (-) (27.8%, p < 0.05 and p < 0.01, respectively). Especially among cases whose preoperative treatment was moderately effective, a multivariate analysis revealed LI to be a favorable prognostic factor independent of other clinicopathologic factors (p = 0.0171). Regarding the preoperative treatment, the incidence of LI (++) was higher in the HCR group (16.9%) than in the CR group (2.0%, p < 0.01). Conclusions: LI appears to be a prognostic predictor after preoperative CR therapy while, in addition, simultaneous hyperthermia may stimulate LI in cases with esophageal cancer.

UR - http://www.scopus.com/inward/record.url?scp=0035312442&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035312442&partnerID=8YFLogxK

U2 - 10.1016/S0360-3016(00)01465-6

DO - 10.1016/S0360-3016(00)01465-6

M3 - Article

C2 - 11286832

AN - SCOPUS:0035312442

VL - 49

SP - 1259

EP - 1266

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 5

ER -